| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$644 |
Fund Payment Notice December 2024
|
25 Feb 2025 10:43AM |
$3.340 |
$3.020 |
fallen by
9.58%
|
|
| BSP Financial Group Limited (BFL) ORDINARY FULLY PAID |
Financials |
$3,883 |
Final Director's Interest Notice - Stuart Arthur Davis
|
25 Feb 2025 10:40AM |
$7.300 |
$8.310 |
risen by
13.84%
|
|
| BSP Financial Group Limited (BFL) ORDINARY FULLY PAID |
Financials |
$3,883 |
Final Director's Interest Notice - Dr. Matagialofi Lua'iufi
|
25 Feb 2025 10:39AM |
$7.300 |
$8.310 |
risen by
13.84%
|
|
| Horizon Oil Limited (HZN) ORDINARY FULLY PAID |
Energy |
$333 |
Notice of FY25 Half Year Financial Results Webcast
|
25 Feb 2025 10:38AM |
$0.203 |
$0.205 |
risen by
1.23%
|
|
| Eagle Mountain Mining Limited (EM2) ORDINARY FULLY PAID |
Materials |
$7 |
Appointment of Executive Director
|
25 Feb 2025 10:37AM |
$0.007 |
$0.006 |
fallen by
14.29%
|
|
| APC Minerals Limited (APC) ORDINARY FULLY PAID |
Materials |
$3 |
Pause in trading
|
25 Feb 2025 10:32AM |
$0.024 |
$0.009 |
fallen by
62.50%
|
|
APC - Price-sensitive ASX Announcement
Full Release
Key Points
- APC Minerals Limited has paused trading in its securities.
- The pause is pending a further announcement.
- This announcement was made via ASX Listings Compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Marmota Limited (MEU) ORDINARY FULLY PAID |
Energy |
$44 |
Investor Update February 2025
|
25 Feb 2025 10:31AM |
$0.053 |
$0.038 |
fallen by
29.25%
|
|
MEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Marmota identifies high-grade gold intersections at Aurora Tank
- Transitioning from discovery to production with emphasis on low-cost methods
- Preparing for resource estimation and pit design at Aurora Tank
- Restarting uranium exploration at Junction Dam
- Significant titanium discovery made at Muckanippie
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$233 |
Appendix 3X - Carolyn Tregarthen
|
25 Feb 2025 10:23AM |
$0.600 |
$0.550 |
fallen by
8.33%
|
|
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$233 |
Appendix 3Z - Murray Boyte
|
25 Feb 2025 10:20AM |
$0.600 |
$0.550 |
fallen by
8.33%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$5,418 |
proposed sale of securities
|
25 Feb 2025 10:18AM |
$104.000 |
$119.880 |
risen by
15.27%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$5,418 |
proposed sale of securities
|
25 Feb 2025 10:17AM |
$104.000 |
$119.880 |
risen by
15.27%
|
|
| Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$8 |
FDA Approves Elate Ocular Phase 3 Clinical Trial Protocol
|
25 Feb 2025 10:15AM |
$0.390 |
$0.460 |
risen by
17.95%
|
|
CMB - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA approval of the Phase 3 clinical trial protocol represents a significant milestone.
- The Phase 3 programme consists of two identical trials designed to meet FDA requirements.
- Trials will be conducted as a Multi-Regional Clinical Trial.
- Protocol approval follows recent FDA Fast Track designation.
- Total enrolment of 800 patients with moderate to severe dry eye disease.
- Co-primary endpoints include changes in corneal staining and eye discomfort scores.
- Cambium Bio anticipates first patient enrolment in mid-2025 and top-line data readout in mid-2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$233 |
Board Changes
|
25 Feb 2025 10:14AM |
$0.600 |
$0.550 |
fallen by
8.33%
|
|
| Omni Bridgeway Limited (OBL) ORDINARY FULLY PAID US PROHIBITED |
Financials |
$398 |
Financial Close of Fund 9
|
25 Feb 2025 10:13AM |
$1.320 |
$1.380 |
risen by
4.55%
|
|
OBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Omni Bridgeway Limited announces financial close of Fund 9.
- Fund 9 established as a continuation fund with Ares Management Corporation.
- Initial payment of A$275 million received for debt repayment and working capital.
- Further payment expected by end of March 2025.
- Total expected proceeds from Fund 9 between A$310 million and A$320 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$76 |
1H FY25 Results and Investor Webinar Notification
|
25 Feb 2025 10:12AM |
$0.500 |
$0.333 |
fallen by
33.50%
|
|
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$233 |
1H25 Investor presentation
|
25 Feb 2025 10:11AM |
$0.600 |
$0.550 |
fallen by
8.33%
|
|
EGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Growth in underlying financial performance and transformative $70.4 million capital raise
- Revenue and earnings growth driven by strong resident demand, rental growth and property valuations
- Underlying EBITDA of $8.2 million, a 16% increase from 1H24
- $22.6 million in revenue, reflecting an 11% increase from 1H24
- Occupancy rate maintained at 97%
- Continued expansion into all-age rental communities targeting essential service workers
- Focus on acquisitions and capital recycling to enhance operational efficiency
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$233 |
1H25 Results Announcement
|
25 Feb 2025 10:11AM |
$0.600 |
$0.550 |
fallen by
8.33%
|
|
EGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue up 11% to $22.6 million.
- Underlying EBITDA increased by 16% to $8.2 million.
- Statutory net profit after tax remained stable at $6.4 million.
- Portfolio value uplift of $4.6 million.
- Significant pipeline of $100m+ in acquisitions.
- Capital recycling program underway with planned asset disposals.
- Final dividend of 0.73 cents per share declared.
- On track for at least 19% underlying EPS growth on FY24.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ironbark Capital Limited (IBC) ORDINARY FULLY PAID |
Financials |
$47 |
Dividend/Distribution - IBC
|
25 Feb 2025 10:10AM |
$0.460 |
$0.445 |
fallen by
3.26%
|
|
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$233 |
Dividend/Distribution - EGH
|
25 Feb 2025 10:08AM |
$0.600 |
$0.550 |
fallen by
8.33%
|
|
| IGO Limited (IGO) ORDINARY FULLY PAID |
Materials |
$3,514 |
Revised Greenbushes CY24 Resources and Reserves
|
25 Feb 2025 10:08AM |
$4.220 |
$4.640 |
risen by
9.95%
|
|
| Voltaic Strategic Resources Ltd (VSR) ORDINARY FULLY PAID |
Materials |
$10 |
Change of Director's Interest Notice - Raihani
|
25 Feb 2025 10:07AM |
$0.012 |
$0.018 |
risen by
50%
|
|
| Bigtincan Holdings Limited (BTH) ORDINARY FULLY PAID |
Information Technology |
- |
Half Year FY24 Results Announcement
|
25 Feb 2025 10:06AM |
$0.210 |
$0.215 |
risen by
2.38%
|
|
BTH - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating revenue of $51.2 million for 1H FY25.
- EBITDA of $2.8 million, a 49% increase from prior period.
- Net loss of $64 million due to goodwill impairment.
- Projected full-year EBITDA of over $10 million.
- Over 200 customer expansions and 50 new logos.
- Ongoing integration of AI technologies into the platform.
- Received 2024 Aragon Research Innovation Award for Sales AI.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$233 |
Appendix 4D and Half Year Financial Report
|
25 Feb 2025 10:03AM |
$0.600 |
$0.550 |
fallen by
8.33%
|
|
EGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities reached $22,557,000, up 11.3%.
- Underlying EBITDA increased by 15.7% to $8,165,000.
- Profit after tax attributable to members was $6,362,000, up 1.0%.
- Earnings per share decreased by 10.9% to 1.86 cents.
- The company declared an interim dividend of 0.73 cents per share.
- Occupancy across rental villages remained stable at 97.3%.
- The company aims to expand its pipeline in the affordable rental sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bigtincan Holdings Limited (BTH) ORDINARY FULLY PAID |
Information Technology |
- |
Half Year Financial Report and Appendix 4D
|
25 Feb 2025 10:03AM |
$0.210 |
$0.215 |
risen by
2.38%
|
|
BTH - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating revenue decreased by 15% to $50.5 million.
- Net loss for the period was $64 million, including a $54 million goodwill impairment.
- EBITDA increased by 49% to $2.8 million.
- Adjusted EBITDA was $5.6 million compared to $5.7 million for the prior period.
- The company completed a retail offer raising approximately $10.5 million.
- A revised loan agreement with Regal Funds Management was established.
- The Board unanimously recommended the Vector Proposal to shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$57 |
MX1 - Extension of Retail Entitlement Offer
|
25 Feb 2025 10:01AM |
$0.070 |
$0.086 |
risen by
22.86%
|
|
MX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Retail Entitlement Offer closing date extended to 14 March 2025
- Eligible shareholders can apply for 1 new share for every 10 shares held
- Issue price for new shares is A$0.07
- The offer includes a 'top-up' facility for additional new shares
- Record date for entitlement is 10 February 2025
- Announcement of results due by 20 March 2025
- Normal trading of new shares will commence on 21 March 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
